These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 6171337

  • 1. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG, Szigeti R, Ernberg I, Masucci G, Klein G, Chessels J, Sieff C, Lie S, Glomstein A, Businco L, Henle W, Henle G, Pearson G, Sakamoto K, Purtilo DT.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [Abstract] [Full Text] [Related]

  • 2. X-linked lymphoproliferative syndrome.
    Sullivan JL, Woda BA.
    Immunodefic Rev; 1989 Nov; 1(4):325-47. PubMed ID: 2561059
    [Abstract] [Full Text] [Related]

  • 3. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT.
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [Abstract] [Full Text] [Related]

  • 4. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [Abstract] [Full Text] [Related]

  • 5. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects.
    Harada S, Sakamoto K, Seeley JK, Lindsten T, Bechtold T, Yetz J, Rogers G, Pearson G, Purtilo DT.
    J Immunol; 1982 Dec; 129(6):2532-5. PubMed ID: 6292290
    [Abstract] [Full Text] [Related]

  • 6. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
    Grierson HL, Skare J, Hawk J, Pauza M, Purtilo DT.
    Am J Med Genet; 1991 Sep 01; 40(3):294-7. PubMed ID: 1683154
    [Abstract] [Full Text] [Related]

  • 7. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [Abstract] [Full Text] [Related]

  • 8. Immunodeficiency as a factor in lymphomagenesis.
    Purtilo DT, Sakamoto K.
    Perspect Pediatr Pathol; 1984 Nov 01; 8(2):181-91. PubMed ID: 6330665
    [Abstract] [Full Text] [Related]

  • 9. Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers.
    Masucci MG, Szigeti R, Ernberg I, Björkholm M, Mellstedt H, Henle G, Henle W, Pearson G, Masucci G, Svedmyr E, Johansson B, Klein G.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4292-301. PubMed ID: 6272973
    [Abstract] [Full Text] [Related]

  • 10. Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome.
    Sakamoto K, Freed HJ, Purtilo DT.
    J Immunol; 1980 Aug 01; 125(2):921-5. PubMed ID: 6248598
    [No Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP).
    Tatsumi E, Purtilo DT.
    AIDS Res; 1986 Dec 01; 2 Suppl 1():S109-13. PubMed ID: 3030340
    [Abstract] [Full Text] [Related]

  • 12. X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma.
    Purtilo DT.
    Arch Pathol Lab Med; 1981 Mar 01; 105(3):119-21. PubMed ID: 6894075
    [Abstract] [Full Text] [Related]

  • 13. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
    Sullivan JL, Byron KS, Brewster FE, Baker SM, Ochs HD.
    J Clin Invest; 1983 Jun 01; 71(6):1765-78. PubMed ID: 6306053
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.
    Int J Oncol; 2004 May 01; 24(5):1165-74. PubMed ID: 15067338
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus-associated lymphoproliferative syndromes: studies in two European families.
    Schuster V, Dohrmann E, Kreth HW.
    Cancer Detect Prev; 1991 May 01; 15(1):65-7. PubMed ID: 1646073
    [Abstract] [Full Text] [Related]

  • 16. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
    Kammermeier-Schmidt U, Weiss M, Belohradsky BH.
    Monatsschr Kinderheilkd; 1993 Mar 01; 141(3):201-6. PubMed ID: 8386321
    [Abstract] [Full Text] [Related]

  • 17. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
    Fark AR.
    J Fam Pract; 1991 Feb 01; 32(2):202, 205-6, 209. PubMed ID: 1846641
    [Abstract] [Full Text] [Related]

  • 18. Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: normal EBV-specific HLA-restricted cytotoxicity.
    Rousset F, Souillet G, Roncarolo MG, Lamelin JP.
    Clin Exp Immunol; 1986 Feb 01; 63(2):280-9. PubMed ID: 3009061
    [Abstract] [Full Text] [Related]

  • 19. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies.
    Purtilo DT, Sakamoto K, Saemundsen AK, Sullivan JL, Synnerholm AC, Anvret M, Pritchard J, Sloper C, Sieff C, Pincott J, Pachman L, Rich K, Cruzi F, Cornet JA, Collins R, Barnes N, Knight J, Sandstedt B, Klein G.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4226-36. PubMed ID: 6272967
    [Abstract] [Full Text] [Related]

  • 20. Abnormal anti-Epstein Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk.
    Sakamoto K, Seeley JK, Lindsten T, Sexton J, Yetz J, Ballow M, Purtilo DT.
    J Immunol; 1982 Feb 01; 128(2):904-7. PubMed ID: 6274962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.